Discovering novel oncogenic pathways and new therapies using zebrafish models of sarcoma
- 1 January 2017
- book chapter
- Published by Elsevier BV
- Vol. 138, 525-561
- https://doi.org/10.1016/bs.mcb.2016.11.011
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- The Histone Methyltransferase SUV39H1 Suppresses Embryonal Rhabdomyosarcoma Formation in ZebrafishPLOS ONE, 2013
- In Vivo Imaging of Tumor-Propagating Cells, Regional Tumor Heterogeneity, and Dynamic Cell Movements in Embryonal RhabdomyosarcomaCancer Cell, 2012
- Subtle variations in Pten dose determine cancer susceptibilityNature Genetics, 2010
- T (brachyury) gene duplication confers major susceptibility to familial chordomaNature Genetics, 2009
- Construction and application of a zebrafish array comparative genomic hybridization platformGenes, Chromosomes and Cancer, 2008
- Genetic Modeling of Ras‐Induced Human RhabdomyosarcomaMethods in Enzymology, 2008
- Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic ZebrafishOncogene, 2008
- Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationBritish Journal of Cancer, 2007
- Germline mutations in HRAS proto-oncogene cause Costello syndromeNature Genetics, 2005
- High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in miceCurrent Biology, 1998